Tonghua Jinma (000766.SZ) plans to invest 70 million yuan to establish Guilin Jinma Innovation Investment Co., Ltd.

Zhtng cijng APP xn, tnghu jnm (000766.SZ) fb gnggo, gnj gngs zhngt zhnlu guhu h ynf yw xqi, gngs n shyu hu zchu zjn 7000 wn yun tuz shl qunz zgngs guln jnm chungxn tuz yuxin gngs. Bnc shl qunz zgngs sh wiro gngs xing chungxn qdng xnghu y xinghu yoq yz zhunxing fzhn zhnlu jnxng, jiqing kizhn chungxn yo chny de bnggu h bj, tgo gngs hxn jngzhng l, wi gngs de chngq k chx fzhn zhr xn dngl. Smart Finance APP News, Tonghua Jinma (000766.SZ) announced that, according to the company's overall strategic planning and R&D business needs, the company plans to use its own or self-raised funds of 70 million yuan to invest in setting up a wholly-owned subsidiary, Guilin Jinma Innovation Investment Co., Ltd. The establishment of this wholly-owned subsidiary is in line with the company's strategy of transforming into an innovative-driven modern pharmaceutical enterprise, strengthening the acquisition and layout of the innovative drug industry, enhancing the company's core competitiveness, and injecting new impetus into the company's long-term sustainable development.